Trials / Conditions / Neoadjuvant Non-Small Cell Lung Cancer
Neoadjuvant Non-Small Cell Lung Cancer
3 registered clinical trials studyying Neoadjuvant Non-Small Cell Lung Cancer — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Lorlatinib Compared with Concurrent/ Sequential Chemoradiotherapy in Stage III ALK Positive Lung Adenocarcinom NCT06858410 | Guangdong Association of Clinical Trials | Phase 3 |
| Not Yet Recruiting | Lorlatinib as Neoadjuvant Treatment in Stage IB-IIIB ALK-rearranged Non-Small Cell Lung Cancer NCT06682884 | Peking University People's Hospital | Phase 2 |
| Active Not Recruiting | A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab NCT05081609 | Ascendis Pharma Oncology Division A/S | Phase 1 / Phase 2 |